| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C331-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C65-21 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C331-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C65-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-38 |
| filingDate |
1988-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1989-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aedb5838d6cd28f52ca3f0de30de2419 |
| publicationDate |
1989-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4839366-A |
| titleOfInvention |
Methylthioquinolyl guanidine derivative, process of preparation thereof and pharmaceutical compositions therefrom |
| abstract |
The compound of formula (I): <IMAGE> I N-cyclohexyl-N''-4-(2-methylthioquinolyl)-N'-2-thiazolyl-guanidine and pharmaceutically acceptable salts thereof is a valuable antiinflammatory, analgesic and antipyretic agent. The compound of the invention may be formulated with conventional pharmaceutically acceptable carriers or diluents to provide a pharmaceutical composition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4889935-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006155101-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6903094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5574885-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6410561-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006030565-A1 |
| priorityDate |
1983-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |